Prevalence of β-hemolytic groups C and F streptococci in patients with acute pharyngitis

North American Journal of Medical Sciences

Volumn 3, Issue 3, 2011, Pages 129-136

  Al Charrakh, Alaa H ^a   Al Khafaji, Jawad K T ^a   Al Rubaye, Rana H S ^a  

^a UNIVERSITY OF BABYLON   (Iraq)

Author keywords

hemolytic streptococci; Group C and F; Streptococcus anginosus

Indexed keywords

AMPICILLIN; CEFEPIME; CEFOTAXIME; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; OFLOXACIN; TETRACYCLINE; VANCOMYCIN; VIRULENCE FACTOR;

AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BETA HEMOLYTIC STREPTOCOCCUS; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRESCHOOL CHILD; PREVALENCE; STREPTOCOCCAL PHARYNGITIS; STREPTOCOCCUS ANGINOSUS; STREPTOCOCCUS GROUP C; STREPTOCOCCUS GROUP F; THROAT CULTURE;

EID: 79953254162     PISSN: None     EISSN: 19472714     Source Type: Journal    
DOI: 10.4297/najms.2011.3129     Document Type: Article

References (42)

1. Whiley RA, Beighton D. Emended description and recognition of Streptococcusconstellatus, Streptococcus intermedius, and Streptococcus anginosus as distinct species. Int J Syst Bacteriol 1991; 41:1-5.
2. Belko J, Goldman DA, Marcone A, Zaidi AK. Clinically significant infections with organisms of the Streptococcus milleri group. Pediatr Infect Dis J 2002; 21:715-723.
3. ReiBmann S, Friedrichs C, Rajkumari R, et al. Contribution of Streptococcus anginosusto Infections Caused by Groups C and G Streptococci, Southern India. Emerg Infect Dis 2010; 16:656-663.
4. Meier FA, Centor RM, Graham L, et al. Clinical and microbiological evidence for endemic pharyngitis among adults due to group C streptococci. Arch Intern Med 1990; 150:825-829.
5. Turner JC, Hayden GF, Kiselica D, et al. Association of group C beta-hemolytic streptococci with endemic pharyngitis among college students. JAMA 1990; 264:2644-2647.
6. Benjamin J, Perriello VA. Pharyngitis due to group C hemolytic streptococci in children. J Pediatr 1976; 89:254-255.
7. Cimolai N, Elford RW, Bryan L, et al. Do non-group A strep cause endemic pharyngitis? Rev Infect Dis 1988; 10:587-601.
8. Lebrun L, Gulbert M, Wallet P, et al. Human Fc (gamma) receptors for differentiation in throat cultures of group C "Streptococcus equisimilis" and group C "Streptococcus milleri.". J Clin Microbiol 1986; 24:705-707.
9. Fox K, Turner J, Fox A. Role of Beta-Hemolytic Group C Streptococci in Pharyngitis: Incidence and Biochemical Characteristics of Streptococcus equisimilis and Streptococcus anginosus in Patients and Healthy Controls. J Clin Microbiol 1993; 31(4):804-807.
10. Gossling J. Occurrence and pathogenicity of the Streptococcus milleri group. Rev Infect Dis 1988; 10: 257-285.
11. Arala-Chaves MP, Porto MT, Arnaud P. Fractionation and characterization of the immunoinfpressive substance in crude extracellular products released by Streptococcus intermedius. J Clin Invest 1981; 68 (1):294-302.
12. Jacobs JA, Stobberingh EE. In-vitro antimicrobial Susceptibility of the "Streptococcus milleri" group (Streptococcus anginosus, Streptococcus constellatus and Streptococcus intermedius). J Antimicrob Chemother 1996; 37:371-375.
13. Asmah N, Eberspächer B, Regnath T, et al. Prevalence of erythromycin and clindamycin resistance among clinical isolates of the Streptococcus anginosus group in Germany. J Med Microbiol 2009; 58:222-227.
14. th ed., Mosby Elsevier Company, USA; 2007.
15. Piret J, Millet J, Demain A. Production of intracellular protease during sporulation of Bacillus brrevis. Eur J Appl Microbiol Biotechnol 1983; 17: 227-230.
16. Sambrook J, Rusell DW. Molecular cloning. A laboratory manual. Third ed. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press, NY; 2001.
17. A1-Qassab AO, Al-Khafaji ZM. Effect of different conditions on inhibition activity of enteric lactobacilli against diarrhea-causing enteric bacteria. J Agric Sci 1992; 3(1):18-26.
18. Wolfe AJ, Berg HG. Migration of bacteria in semisolid agar. Proc. Natl. Acad Sci 1989; 86:6973-6977.
19. National Committee for Clinical Laboratory Standards (NCCLS). Performance standards for disc susceptibility tests, 8th ed. Approved standard M2-A8. National Committee for Clinical Laboratory Standards, Wayne, Pa; 2003.
20. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing. Approved standard M100-S20. Vol. 30, No. 1. National Committee for Clinical Laboratory Standards, Wayne, PA. USA; 2010.
21. WHO. Techniques for the detection of β- lactamase producing strains of Neisseria gonorrhoeae. 1978; 616:137-143.
22. National Committee for Clinical Laboratory Standards (NCCLS). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard, 6th ed. M7-A6. National Committee for Clinical Laboratory Standards, Wayne, Pa; 2003.
23. Lewis RFM, Balfour AE. Group C streptococci isolated from throat swabs: a laboratory and clinical study. J Clin Pathol 1999; 52:264-266.
24. Jacobs JA, Pietersen HG Stobberingh EE, et al. Streptococcus anginosus, Streptococcus constellatus and Streptococcus intermedius. Clinical relevance, hemolytic and serologic characteristics. Am Int Clin Pathol 1995; 104:547-553.
25. Lawrence J, Yajko DM., Hadley WK. Incidence and characterization of beta-hemolytic Streptococcus milleri and differentiation from Strep. payogenes (group A), S. equisimilis (group C), and large colony group G streptococci. J Clin Microbiol 1985; 22: 772-777.
26. Whiley RA, Hardie JM, Beighton D. Phenotypic differentiation of Streptococcus intermedius, Streptococcus constellatus, and Streptococcus anginosus strains with the Streptococcus milleri group.J Clin Microbiol 1990; 28:1497-1501.
27. Ball LC, Parker MT. The cultural and biochemical characters of Streptococcus milleri strains isolated from human sources. J Hyg 1979; 82:63-78.
28. Bridge PD, Sneath PH. Numerical taxonomy of Streptococcus. J Gen Microbiol 1983; 129:565-597.
29. Ruoff KL, Ferraro MJ. Hydrolytic enzymes of Streptococcus milleri. J Clin Microbiol 1987; 25 (9): 1645-1647.
30. Handley PS, Carter PL, Wyatt JE, et al. Surface structures (peritrichous fibrils and tufts of fibrils) found on Streptococcus sangguis strains may be related to their ability to coaggregate with other oral genera. Infect Immun 1985; 47:217-227.
31. Schofield CR, Tagg JR. Bacteriocin-like activity of group B and group C streptococci of human and of animal origin. J Hyg Camb 1983; 90:7-18.
32. Bergman S, Selig M, Collins JA, et al. "Streptococcus milleri" Strains displaying a gliding type of motility. Int J Syst Bacteriol 1995; 45:235-239.
33. Clermont D, Horaud T. Identification of chromosomal antibiotic resistance genes in Streptococcus anginosus ("Strep. milleri"). Antimicrob Agents Chemother 1990; 34:1685-1690.
34. Melia M, Auwaerter P. Streptococcus species. Endorsed by the Infect. Dis. Society of America, circulation; 2009:394-434.
35. Limia A, Jimenez ML, Alarcón T, et al.Five-year analysis of antimicrobial susceptibility of the Streptococcus milleri group. Eur J Microbiol Infect Dis 1999; 18: 440-444.
36. Gomez-Garcés JL, Alos JI, Cogollos R. Bacteriologic characteristics and antimicrobial susceptibility of 70 clinically significant isolates of Streptococcus milleri group. Diagn Microbiol Infect Dis 1994; 19:69-73.
37. Alcaide F, Linares J, Pallares R, et al. In vitro activities of 22 β-lactam antibiotics against penicillin-resistant and penicillin-susceptible viridians group streptococci isolated from blood. Antimicrob Chemother 1995; 39:2243-2247.
38. Ruoff KL. Streptococcus anginosus (Streptococcus milleri): The unrecognized pathogen. Clin Microbiol Rev 1988; 1:102-108.
39. Zaoutis T, Schnieder B, Moore LS, et al. Antibiotic susceptibilities of group C and group G streptococci isolated from patients with invasive infections: evidence of vancomycin tolerance among group G serotypes. J Clin Microbiol 1999; 37:3380-3383.
40. Noble JT, Tyburski MB, Berman M, et al. Antimicrobial tolerance in group G streptococcus. Lancet 1980; ii:982.
41. Horodniceanu T, Bouguelert L, Bieth G. Conjugative transfer of multiple-antibiotic resistance markers in β-hemolytic group A, B, F and G streptococci in the absence of extrachromosomal deoxyribonucleic acid. Plasmids 1981; 5:127-137.
42. Citron DM, Goldstein EJC, Merriam C V, et al. Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents. J Clin Microbiol 2007; 45:2819-2828.